Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Significant information about advances in treating or understanding the major neurological diseases always emerges from the annual meeting of the American Academy of Neurology. Here are summaries of some noteworthy reports presented at this year's conference in Chicago. Multiple Sclerosis Treatment of multiple sclerosis (MS) by plasmapheresis was the subject of three reports of varying degrees of enthusiasm. In eight cases of progressive MS so treated, there was "definite evidence of improvement," reported Peter Dau, MD, of Children's Hospital, San Francisco. The treatment comprised one exchange (involving 3 to 5 L of plasma) each week for six to ten weeks. However, Dau said, even though plasmapheresis was continued for nine months, the "bulk of the disability was not improved." Similar observations came from Howard Weiner, MD, of Harvard Medical School, and Floyd Davis, MD, of Rush-Presbyterian-St Luke's Medical Center in Chicago. Weiner, for instance, found "modest but unequivocal" improvement lasting
JAMA – American Medical Association
Published: Jul 27, 1979
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.